Share

February 18, 2020; 94 (7) Article

Effects of periconceptional folate on cognition in children of women with epilepsy

NEAD study

Kimford J. Meador, Page B. Pennell, Ryan C. May, Carrie A. Brown, Gus Baker, Rebecca Bromley, David W. Loring, Morris J. Cohen, for the NEAD Investigator Group
First published December 23, 2019, DOI: https://doi.org/10.1212/WNL.0000000000008757
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
340

Share

Article Information

vol. 94 no. 7 e729-e740
DOI: 
https://doi.org/10.1212/WNL.0000000000008757
PubMed: 
31871217
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 8, 2019
  • Accepted in final form August 21, 2019
  • First Published December 23, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Kimford J. Meador, MD,
    2. Page B. Pennell, MD,
    3. Ryan C. May, PhD,
    4. Carrie A. Brown, MS,
    5. Gus Baker, PhD,
    6. Rebecca Bromley, PhD,
    7. David W. Loring, PhD,
    8. Morris J. Cohen, EdD;
    9. for the NEAD Investigator Group
  1. Kimford J. Meador, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Dr. Meador is on the editorial boards for Neurology, Cognitive & Behavioral Neurology, Epilepsy & Behavior, and Epilepsy & Behavior Case Reports.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Dr. Meador has acted as a consultant for the Epilepsy Study Consortium that receives money from multiple pharmaceutical companies; Dr. Meador has received salary support to his university from the Epilepsy Consortium for research consultant work related to Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma and Vivus Pharmaceuticals. In addition, he is Co-I and Director of Cognitive Core of the Human Epilepsy Project for the Epilepsy Study Consortium.

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Dr. Meador received travel support from UCB Pharma.

    Clinical procedures or imaging studies:

    1. Clinical care of patients with epilepsy.

    Research Support, Commercial Entities:

    1. Dr. Meador received grant research support from Sunovion Pharma.

    Research Support, Government Entities:

    1. Dr. Meador is receiving active research support for NIH/NINDS 2-U01- NS038455-16 Meador (Multi-PI) Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs and for NIH/NINDS # R01NS088748.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Page B. Pennell, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel has been reimbursed by the the American Epilepsy Society, Epilepsy Foundation, and the National Institutes of Health.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. National Institutes of Health, grant reviews.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NIH (NINDS and NICHD) grants #U01 NS038455, multiple Principal Investigator, 2014-present.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ryan C. May, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. 1)The Emmes Company, LLC, Senior Biostatistician Manager, 8 years

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) The Emmes Company, LLC

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Carrie A. Brown, MS,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Emmes, biostatistician, 2 years

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Gus Baker, PhD,
    6. Scientific Advisory Boards:

    1. Sanofi Aventis 2009- Advising on research investigating the neurodeveolmental effects of AED treatment. UCB 2009 - Principal investigator for study investigating neurodevelopmental effects of treatment of AED treatment Epilepsy Research UK 2010 - Principal investigator for study investigating neurodevelopmental effects of treatment of novel AED treatment

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Funding to present research at the ILAE UK meeting UCB 2012 Expert witness for class action involving the production of an unsafe drug by Sanofi Aventis 2015

    Editorial Boards:

    1. Editorial Board of Epilepsy and Behaviour 2002 - Editorial Board for Seizure 2000 - Editorial Board for Epilepsy Research 2002

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Educational Grant from UCB Pharma [PI] 2009 - 2010 Educational Grant from Sanofi Aventis [PI] 2005 - 2010 Educational Grant from Pfizer [PI] 2008-2010 Educational Grant from ERUK 2009-

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Epilepsy Research UK 2009-2011 Principal Investigator Medical Research Council 2009-2011 Co-Prinicipal Investigator Epilepsy Action UK Principal Investigator 2009-2011

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Rebecca Bromley, PhD,
    7. Scientific Advisory Boards:

    1. During the period of this study I gave two presentations to advisory boards for Sanofi Aventis. I was paid for these ($1000.00 in total) but this money went to my hospital or to charity.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. During the period of this study I worked on another study where my salary was supported through an educational grant from Sanofi Aventis.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Epilepsy Research UK.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. I provided expert testimony regarding fetal valproate syndrome in the UK; although this case did not go to court.

  7. David W. Loring, PhD,
    8. Scientific Advisory Boards:

    1. Professional Advisory Board, Epilepsy Foundation

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Received travel expenses and honoraria for educational activities funded by NeuroPace.

    Editorial Boards:

    1. 1. Neuropsychology Review, Editor in Chief, 2015- 2. Epilepsia, Associate Editor, 2013- 3. Archives of Clinical Neuropsychology, Editorial Board, 2016

    Patents:

    1. NONE

    Publishing Royalties:

    1. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. New York: Oxford University Press, 2004 Loring DW, ed. INS dictionary of neuropsychology and clinical neurosciences (2nd edition). New York: Oxford University Press, 2015

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NeuroPace, consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. Neuropsychological Testing - 90%

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1 R01 MH118514-01 National Neuropsychological Network (NNN) 03/04/2019 – 01/31/2024 Site PI 2U01NS038455-16A1 Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) 05/15/2018 - 02-28-2023

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Morris J. Cohen, EdD;
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Children's Memory Scale, The Psychological Corporation, Pearson, 1997 to present.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. for the NEAD Investigator Group
  1. From the Department of Neurology and Neurological Sciences (K.J.M.), Stanford University, CA; Department of Neurology (P.B.P.), Brigham and Women's Hospital, Harvard Medical School, Boston; The Emmes Corporation (R.C.M., C.A.B.), Rockville, MD; Walton Centre for Neurology & Neurosurgery (G.B.), University of Liverpool, Merseyside; Division of Evolution and Genomic Science (R.B.), School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK; Departments of Neurology and Pediatrics (D.W.L.), Emory University, Atlanta; and Pediatric Neuropsychology International (M.J.C.), Augusta, GA.
  1. Correspondence
    Dr. Meador kmeador{at}stanford.edu
View Full Text

Article usage

Article usage: December 2019 to April 2023

AbstractFullPdfSource
Dec 2019269012Highwire
Jan 2020354027Highwire
Feb 20206739248Highwire
Mar 20202843833Highwire
Apr 2020982121Highwire
May 20202481515Highwire
Jun 20206823Highwire
Jul 202010065Highwire
Aug 2020611122Highwire
Sep 2020791517Highwire
Oct 20207476Highwire
Nov 20207164Highwire
Dec 2020631411Highwire
Jan 202112648Highwire
Feb 20218739Highwire
Mar 202167911Highwire
Apr 202160158Highwire
May 20218679Highwire
Jun 20216134Highwire
Jul 20216042Highwire
Aug 20215700Highwire
Sep 20214436Highwire
Oct 20218596Highwire
Nov 202115844Highwire
Dec 20217413Highwire
Jan 20225865Highwire
Feb 20225610Highwire
Mar 20227943Highwire
Apr 20227443Highwire
May 20229111Highwire
Jun 20226923Highwire
Jul 20224812Highwire
Aug 20225466Highwire
Sep 202211093Highwire
Oct 202211912Highwire
Nov 20228030Highwire
Dec 202263118Highwire
Jan 20236993Highwire
Feb 20235064Highwire
Mar 20235421Highwire
Apr 20236842Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Related Articles

Topics Discussed

Alert Me

Recommended articles